Skip to main content

BIOSTATNET 2025: FORTALECIENDO LA INVESTIGACION DE EXCELENCIA EN BIOESTADISTICA A NIVEL NACIONAL E INTERNACIONAL

RED2024-153680-T

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Transferencia y Colaboración
Subprogram Subprograma Estatal para impulsar la Colaboración en y entre los Sectores Público y Privado
Call Redes Investigación /Redes Excelencia
Call year 2024
State Plan 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Multivariate spatio-temporal modelling for completing cancer registries and forecasting incidence

  • Retegui Goñi, Garazi
  • Etxeberria Andueza, Jaione
  • Ugarte Martínez, María Dolores
Cancer data, particularly cancer incidence and mortality, are fundamental to understand the cancer burden, to set targets for cancer control and to evaluate the evolution of the implementation of a cancer control policy. However, the complexity of data collection, classification, validation and processing result in cancer incidence figures often lagging two to three years behind the calendar year. In response, national or regional population-based cancer registries (PBCRs) are increasingly interested in methods for forecasting cancer incidence. However, in many countries there is an additional difficulty in projecting cancer incidence as regional registries are usually not established in the same year and therefore cancer incidence data series between different regions of a country are not harmonized over time. This study addresses the challenge of forecasting cancer incidence with incomplete data at both regional and national levels. To achieve this, we propose the use of multivariate spatio-temporal shared component models that jointly model mortality data and available cancer incidence data. We evaluate the performance of these multivariate models using lung cancer incidence data and the corresponding number of deaths reported in England for the period 2001-2019. Model performance was assessed using different predictive measures to select the best model., The work was supported by Project PID2020-113125RB-I00/MCIN/AEI/10.13039/501100011033, Ayudas Predoctorales Santander UPNA 2021-2022 and Research Networks Project BIOSTATNET AEI/RED2024-153680-T. Open access funding provided by Universidad Pública de Navarra.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Prior smoothing for multivariate disease mapping models

  • Retegui Goñi, Garazi
  • Ugarte Martínez, María Dolores
  • Etxeberria Andueza, Jaione
  • Gelfand, Alan E.
To date, we have seen the emergence of a large literature on multivariate disease mapping. That is, incidence of (or mortality from) multiple diseases is recorded at the scale of areal units where incidence (mortality) across the diseases is expected to manifest dependence. The modeling involves a hierarchical structure: a Poisson model for disease counts (conditioning on the rates) at the first stage, and a specification of a function of the rates using spatial random effects at the second stage. These random effects are specified as a prior and introduce spatial smoothing to the rate (or risk) estimates. What we see in the literature is the amount of smoothing induced under a given prior across areal units compared with the observed/empirical risks. Our contribution here extends previous research on smoothing in univariate areal data models. Specifically, for three different choices of multivariate prior, we investigate both within prior smoothing according to hyperparameters and across prior smoothing. Its benefit to the user is to illuminate the expected nature of departure from perfect fit associated with these priors, providing information about their smoothing behavior that is not captured by conventional measures of predictive performance. We propose both theoretical and empirical metrics for our investigation and illustrate with both simulated and real data., G.R., J.E., and M.D.U. were supported by Project PID2024-155382OB-I00 funded by MICIU/AEI/10.13039/501100011033 and FEDER, UE. This work was also supported by BIOSTATNET - Proyectos redes de investigación 2024 - RED2024-153680-T/MICIU/AEI/.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

On prior smoothing with discrete spatial data in the context of disease mapping

  • Retegui Goñi, Garazi
  • Gelfand, Alan E.
  • Etxeberria Andueza, Jaione
  • Ugarte Martínez, María Dolores
Disease mapping attempts to explain observed health event counts across areal units, typically using Markov random field models. These models rely on spatial priors to account for variation in raw relative risk or rate estimates. Spatial priors introduce some degree of smoothing, wherein, for any particular unit, empirical risk or incidence estimates are either adjusted towards a suitable mean or incorporate neighbor-based smoothing. While model explanation may be the primary focus, the literature lacks a comparison of the amount of smoothing introduced by different spatial priors. Additionally, there has been no investigation into how varying the parameters of these priors influences the resulting smoothing. This study examines seven commonly used spatial priors through both simulations and real data analyses. Using areal maps of peninsular Spain and England, we analyze smoothing effects using two datasets with associated populations at risk. We propose empirical metrics to quantify the smoothing achieved by each model and theoretical metrics to calibrate the expected extent of smoothing as a function of model parameters. We employ areal maps in order to quantitatively characterize the extent of smoothing within and across the models as well as to link the theoretical metrics to the empirical metrics., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work was supported by Project PID2020-113125RB-I00/MCIN/AEI/10.13039/501100011033, PID2024-155382OB-I00 funded by MICIU/AEI/10.13039/501100011033 and FEDER, UE and BIOSTATNET - PROYECTOS REDES DE INVESTIGACIÓN 2024 - RED2024-153680-T/MICIU/AEI/. Garazi Retegui is supported by PhD student scholarship from the Public University of Navarra together with Banco Santander (Ayudas Predoctorales Santander UPNA 2021-2022). Jaione Etxeberria and María Dolores Ugarte would like to acknowledge support from Project UNEDPAM/PI/PR24/05A.